• European subsidiary role: Dhanuka incorporated Dhanuka Agritech Europe Private Limited to manage regulatory registrations, clearances, and commercial distribution for two acquired Bayer products across global markets.
• Revenue and margins: Due to weak monsoon conditions across India, the company expects lower single-digit revenue growth, while portfolio rationalization and six upcoming launches are planned to contain the EBITDA margin drop to 200 basis points.
• Nagpur plant expansion: Commissioning is slated for March 2028 with full operations four to five months later, and the facility is projected to generate ₹400 to ₹500 crore in revenue.
• Dahej facility outlook: Dahej revenue is guided to reach ₹75 crore in FY27—representing 50% growth—with operational breakeven targeted for FY28.
• Acquired Bayer portfolio: The products are already delivering meaningful domestic and international revenue, with Bayer continuing distribution across global markets like Europe and Brazil.